sameAs
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transitionImmunosuppressive treatment for focal segmental glomerulosclerosis in adultsImmunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndromeImmunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndromeRelative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotypeDisruption of the Ang II type 1 receptor promotes longevity in miceGenetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcomePanethnic Differences in Blood Pressure in Europe: A Systematic Review and Meta-AnalysisKey fibrogenic mediators: old players. Renin–angiotensin systemIs ADAMTS-13 deficiency specific for thrombotic thrombocytopenic purpura? NoPrevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspectiveThrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpuraThe endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathyAlternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosisEculizumab in a patient with dense-deposit diseaseThe interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural modelsIn vivo maturation of functional renal organoids formed from embryonic cell suspensionsNeurological symptoms and coma associated with doxorubicin administration during chronic cyclosporin therapyIncreased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosisAngiotensin-converting enzyme inhibition prevents glomerular-tubule disconnection and atrophy in passive Heymann nephritis, an effect not observed with a calcium antagonistACE inhibition and ANG II receptor blockade improve glomerular size-selectivity in IgA nephropathyEstimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013: Findings From the Global Burden of Disease 2013 StudyTranslating the basic knowledge of mitochondrial functions to metabolic therapy: role of L-carnitineErythropoietin enhances immunostimulatory properties of immature dendritic cellsEffects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathyChild and Adolescent Health From 1990 to 2015: Findings From the Global Burden of Diseases, Injuries, and Risk Factors 2015 Study.Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013Cardiovascular risk assessment in low-resource settings: a consensus document of the European Society of Hypertension Working Group on Hypertension and Cardiovascular Risk in Low Resource SettingsHealth services: an Italian market.In response to protein load podocytes reorganize cytoskeleton and modulate endothelin-1 gene: implication for permselective dysfunction of chronic nephropathiesSize regulation of von Willebrand factor-mediated platelet thrombi by ADAMTS13 in flowing bloodHeparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial.MYO1E mutations and childhood familial focal segmental glomerulosclerosis.Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.Automatic generation of glomerular capillary topological organization.Experimental Evaluation of Kidney Regeneration by Organ Scaffold RecellularizationAngiotensin-converting enzyme inhibition and renal protection in nondiabetic patients: the data of the meta-analyses.Ramipril prolongs life and is cost effective in chronic proteinuric nephropathies.
P50
Q21034169-DAAD38A0-1B50-4DB6-AE7B-2393DEF6294FQ24170269-4B6A0F3E-C4EC-411B-A7B1-1F0996A8F8B9Q24242266-6D1376B4-CA63-47FF-9F90-D328672F4B80Q24246172-0A823BC8-88B6-4107-9F1E-636A40098211Q24248134-22FD7407-6F3F-4119-AD0F-A9F61573E651Q24613907-088ED6E0-928C-4244-A9F6-F0BF4B670466Q24647615-3B9B4FC2-D442-4905-A1BA-D85171D33C70Q24685473-75229E5A-F0C2-4818-926A-DD1929A68470Q26774838-4D21ADB3-E9CB-4782-A6EA-2265939346FDQ26796631-512D60E7-0B82-454E-B18E-3D6C0C3B7CD2Q28188198-EF5BD9FD-291E-40BA-9D08-A67C3E05DFBCQ28196527-3BF7637E-7FF4-463F-81A6-8350E38CADB2Q28214974-45FE1A7D-83AE-4803-8B47-26FDCD300AF2Q28237978-E11133A3-574B-4FDC-9D0B-F067DFBBA7D3Q28239591-254B573C-6BEE-48C2-8E1E-AA7D976C2D7DQ28262415-9D63164C-D721-4FB3-9D21-847BEF2882B0Q28272816-BA541A07-B803-4964-A00E-6EDD9E3B555DQ28277647-1460375B-C91E-42CC-8161-F09FE085F8FFQ28327484-92BD24D2-5038-449C-9527-0378339D1438Q28362606-C3811C6B-EE94-4800-ADF4-29F5AAEF10C2Q28363381-F3B1EABC-8AE4-434D-8108-5F57D4DAF207Q28370950-BCDAEE15-231B-470B-9063-7B6C914A7B13Q28370950-EB660141-E0A3-49C6-AC1A-268F66C9D76FQ28391248-5997345D-B8B1-48B9-93D1-59B38BA47684Q28392340-243F7FDB-578E-458E-BDF7-1797FB76D73EQ28395286-C3C74A12-C4F0-4192-98CD-798454E02BCBQ28583929-5075C7F1-CA83-42B6-8E6D-07EA0F1791D7Q29615215-405E0414-5D8C-44A2-B0D7-7C73C227E5C3Q30252707-0109FA9B-B592-49E0-BC8C-4DE1FE4E5C9FQ30358426-79DBCF58-0DA7-4844-AA08-A75172FD0406Q30391917-B1125E92-414E-4971-A57E-5F7E29CD7FDCQ30424123-DD9EF1D9-B503-49E4-BD39-824D39021535Q30445152-7E8ABBC0-4268-45E7-B4B3-2D3A4AE31C25Q30479643-249FE426-354D-4F5F-9452-F528F77B2E13Q30512857-B719A05D-3645-4CCE-9D77-AEAA6EAFBA65Q30541167-32C7B932-FFE2-4337-B0A2-9876E62C51C7Q30656350-C6E7FA4D-04A6-4217-B19F-2B0EAE6CA3D4Q30756159-E93B6ECC-C843-4C9B-82FA-55F331C3C48EQ30840855-5B02D55B-AD49-4648-B410-40BABADC4B84Q30991469-944636D0-69C0-4198-BD77-82D5F3E86E8A
P50
description
Itaalia arst
@et
Italiaans arts
@nl
Italian physician
@en
Italian physician
@en-ca
Italian physician
@en-gb
dochtúir Iodálach
@ga
dokter asal Italia
@id
italienischer Arzt
@de
medic italian
@ro
medico italiano
@it
name
Giuseppe Remuzzi
@ast
Giuseppe Remuzzi
@ca
Giuseppe Remuzzi
@de
Giuseppe Remuzzi
@en
Giuseppe Remuzzi
@es
Giuseppe Remuzzi
@fr
Giuseppe Remuzzi
@ga
Giuseppe Remuzzi
@it
Giuseppe Remuzzi
@nl
Giuseppe Remuzzi
@sl
type
label
Giuseppe Remuzzi
@ast
Giuseppe Remuzzi
@ca
Giuseppe Remuzzi
@de
Giuseppe Remuzzi
@en
Giuseppe Remuzzi
@es
Giuseppe Remuzzi
@fr
Giuseppe Remuzzi
@ga
Giuseppe Remuzzi
@it
Giuseppe Remuzzi
@nl
Giuseppe Remuzzi
@sl
altLabel
G. Remuzzi
@en
Remuzzi
@en
Remuzzi, G.
@en
prefLabel
Giuseppe Remuzzi
@ast
Giuseppe Remuzzi
@ca
Giuseppe Remuzzi
@de
Giuseppe Remuzzi
@en
Giuseppe Remuzzi
@es
Giuseppe Remuzzi
@fr
Giuseppe Remuzzi
@ga
Giuseppe Remuzzi
@it
Giuseppe Remuzzi
@nl
Giuseppe Remuzzi
@sl
P106
P214
P227
P244
P103
P1053
V-9766-2017
P1153
56466188600
P1559
Giuseppe Remuzzi
@it
P19
P21
P213
0000 0000 5836 0739
0000 0000 7367 8286
P214
P227
1137964952